Solasta Bio Limited
USPTO PatentsView assignee record - 8 granted patents across 3 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01P (Biocidal, Pest Repellant, Pest Attractant OR Plant Growth Regulatory Activity OF Chemical Compounds OR Preparations).
The verdict
According to USPTO PatentsView, Solasta ranks #33,377 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 3 technology areas.
- #33,377
- of 49,997 US assignees by volume
- 20th percentile
- by Innovation Score (26.5/100)
- 10.1
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R33377 · Foreign Corporation #33,377 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 8 grants
- MID-PACK #33,377/49,997
- PHOTO-FINISH Smylio
- CPC-NARROW A01P · 3 areas
- INNOV-THIN 26.5/100
- CLAIMS-PAR 10.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2024–2025 · 2y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Smylio Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Solasta’s 26.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Solasta
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Solasta Bio · this assignee 26
Solasta Bio · this assignee
26 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Solasta's Innovation Score is 26.5/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Solasta?
Each dot is one of Solasta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Solasta’s own 10.1 claims/patent is at or below the 13.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Solasta's grants concentrate
Solasta Bio Limited is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A01P (Biocidal, Pest Repellant, Pest Attractant OR Plant Growth Regulatory Activity OF Chemical Compounds OR Preparations). By volume, Solasta sits between Smylio Inc. and Sophono, Inc..
Solasta's three-year grant acceleration
Solasta Bio Limited shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Solasta's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Smylio
Smylio Inc.
8 patents
- Socket Solutions
Socket Solutions, LLC
8 patents
- Socrates Health S…
Socrates Health Solutions, Inc.
8 patents
- Sofsera
SofSera Corporation
8 patents
- Solvay Advanced P…
Solvay Advanced Polymers, L.L.C.
8 patents
- Sonic Blocks
Sonic Blocks, Inc.
8 patents
- Sonoma Pharmaceut…
Sonoma Pharmaceuticals, Inc.
8 patents
- Sophono
Sophono, Inc.
8 patents
- Solasta Bio ◀
Solasta Bio Limited
8 patents
What this shows Solasta holds 8 patents at rank #33,426, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Solasta
By rank, the assignees closest to #33,426 in granted patent volume.
- Smylio Inc. #33,422 · 8 patents
- Socket Solutions, LLC #33,423 · 8 patents
- Socrates Health Solutions, Inc. #33,424 · 8 patents
- SofSera Corporation #33,425 · 8 patents
- Solvay Advanced Polymers, L.L.C. #33,427 · 8 patents
- Sonic Blocks, Inc. #33,428 · 8 patents
- Sonoma Pharmaceuticals, Inc. #33,429 · 8 patents
- Sophono, Inc. #33,430 · 8 patents
Leaders in A01P (Biocidal)
Other assignees with the most granted patents in Solasta's primary technology class.
Solasta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
26 20th percentile higher than 20% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 1 | 12.5% |
| 2025partial year | 7 | 87.5% |
Which technologies does Solasta Bio Limited patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Solasta Bio Limited's patent record in context - here's where to go next.
- Solasta Bio Limited's lead technology class is A01P (Biocidal, Pest Repellant, Pest Attractant OR Plant Growth Regulatory Activity OF Chemical Compounds OR Preparations), 100% of its portfolio - see every assignee active in that class. Explore A01P
- Ranked #33,377 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Solasta Bio Limited against Smylio Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.